ArticleJournal for immunotherapy of cancer2026

Primary and secondary pseudo-stability and progression after atezolizumab with and without bevacizumab.

Saiabhiroop Govindu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.